Johan Dalén

770 total citations
29 papers, 534 citations indexed

About

Johan Dalén is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Johan Dalén has authored 29 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 8 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in Johan Dalén's work include Rheumatoid Arthritis Research and Therapies (11 papers), Spondyloarthritis Studies and Treatments (6 papers) and Multiple Sclerosis Research Studies (5 papers). Johan Dalén is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Spondyloarthritis Studies and Treatments (6 papers) and Multiple Sclerosis Research Studies (5 papers). Johan Dalén collaborates with scholars based in United States, Sweden and United Kingdom. Johan Dalén's co-authors include Axel Svedbom, Christopher M. Black, Gisela Kobelt, Daniela Capsa, Jenny Berg, Sumesh Kachroo, Mona Ståhle, Ingemar F. Petersson, Carla Mamolo and Joseph C. Cappelleri and has published in prestigious journals such as Clinical Cancer Research, Annals of the Rheumatic Diseases and European Journal of Cancer.

In The Last Decade

Johan Dalén

28 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johan Dalén United States	14	182	121	117	115	85	29	534
Z. Reguiaï France	17	365 2.0×	246 2.0×	318 2.7×	33 0.3×	37 0.4×	60	834
Angela Nagel Germany	11	239 1.3×	92 0.8×	194 1.7×	48 0.4×	16 0.2×	28	528
Ani John United States	14	70 0.4×	107 0.9×	416 3.6×	41 0.4×	26 0.3×	30	575
Marina Scolnik Argentina	14	73 0.4×	157 1.3×	305 2.6×	45 0.4×	30 0.4×	43	485
Shan‐Fu Yu Taiwan	14	77 0.4×	95 0.8×	242 2.1×	99 0.9×	18 0.2×	45	573
Jeffrey B. Shiroky Canada	12	92 0.5×	111 0.9×	397 3.4×	34 0.3×	30 0.4×	16	669
W.P. Arnold Netherlands	13	48 0.3×	331 2.7×	58 0.5×	79 0.7×	81 1.0×	26	541
Jeffrey Zweegers Netherlands	14	73 0.4×	455 3.8×	99 0.8×	86 0.7×	122 1.4×	19	610
John Waller United Kingdom	10	33 0.2×	94 0.8×	50 0.4×	22 0.2×	76 0.9×	38	415
Liyan Liu China	14	40 0.2×	59 0.5×	163 1.4×	93 0.8×	21 0.2×	31	660

Countries citing papers authored by Johan Dalén

Since Specialization

Citations

This map shows the geographic impact of Johan Dalén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Dalén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Dalén more than expected).

Fields of papers citing papers by Johan Dalén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Dalén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Dalén. The network helps show where Johan Dalén may publish in the future.

Co-authorship network of co-authors of Johan Dalén

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Dalén. A scholar is included among the top collaborators of Johan Dalén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Dalén. Johan Dalén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deodhar, Atul, et al.. (2025). Prevalence of axial spondyloarthritis (axSpA) in patients treated for chronic back pain in chiropractic clinics: the oregon chiropractic axial spondyloarthritis study (ORCAS). Clinical Rheumatology. 44(10). 3981–3991.

Jakobsson, Maria, Angela Strambi, Fredrik Nilsson, Johannes Arpegård, & Johan Dalén. (2024). Real-world experience of second-line axitinib in metastatic renal cell carcinoma: analysis of the Swedish population. Future Oncology. 20(20). 1385–1392. 1 indexed citations

Dalén, Johan, Axel Svedbom, E Hernlund, Tor Olofsson, & Christopher M. Black. (2023). Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication. Advances in Therapy. 40(10). 4657–4674. 3 indexed citations

Lee, Adam, et al.. (2022). Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies. Cancer Treatment and Research Communications. 33. 100648–100648. 5 indexed citations

Dalén, Johan, Amy Puenpatom, Karin Luttropp, Axel Svedbom, & Christopher M. Black. (2021). Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study. Advances in Therapy. 39(1). 244–255. 4 indexed citations

Dalén, Johan, Axel Svedbom, Tor Olofsson, et al.. (2021). Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study. Advances in Therapy. 39(6). 2468–2486. 2 indexed citations

Luttropp, Karin, Johan Dalén, Axel Svedbom, et al.. (2020). <p>Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review</p>. Patient Preference and Adherence. Volume 14. 309–320. 14 indexed citations

Dalén, Johan, Karin Luttropp, Axel Svedbom, Christopher M. Black, & Sumesh Kachroo. (2020). Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study. Advances in Therapy. 37(9). 3746–3760. 3 indexed citations

Dalén, Johan, M Ivergård, Rebekah H. Borse, et al.. (2019). The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis. The European Journal of Health Economics. 21(1). 45–54. 4 indexed citations

10.

Dalén, Johan, Ulrika Harmenberg, Magnus Lindskog, et al.. (2019). <p>Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis</p>. Cancer Management and Research. Volume 11. 1289–1297. 5 indexed citations

11.

Dalén, Johan, Axel Svedbom, Karin Luttropp, & Sumesh Kachroo. (2018). THU0666 Costs associated with switching subcutaneous tumour necrosis factor-Α inhibitor in the treatment of immune-mediated rheumatic disease. Annals of the Rheumatic Diseases. 77. 527–527. 2 indexed citations

12.

Dalén, Johan, Axel Svedbom, Christopher M. Black, & Sumesh Kachroo. (2017). Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitors. Rheumatology International. 37(12). 2049–2058. 16 indexed citations

13.

Svedbom, Axel, Johan Dalén, Christopher M. Black, & Sumesh Kachroo. (2017). Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line. Patient Preference and Adherence. Volume 11. 95–106. 17 indexed citations

14.

Selmaj, Krzysztof, Gisela Kobelt, Jenny Berg, et al.. (2017). New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland. Multiple Sclerosis Journal. 23(2_suppl). 130–142. 15 indexed citations

15.

Dalén, Johan, Axel Svedbom, Christopher M. Black, et al.. (2016). Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence. Rheumatology International. 36(7). 987–995. 50 indexed citations

16.

Hsieh, Ruey Kuen, Alexandre Chan, Hoon-Kyo Kim, et al.. (2014). Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Supportive Care in Cancer. 23(1). 263–272. 46 indexed citations

17.

Svedbom, Axel, Johan Dalén, Carla Mamolo, et al.. (2014). Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study. Acta Dermato Venereologica. 95(7). 0–0. 51 indexed citations

18.

Picelli, Simone, Paweł Zając, Xiaolei Zhou, et al.. (2010). Common variants in human CRC genes as low-risk alleles. European Journal of Cancer. 46(6). 1041–1048. 52 indexed citations

19.

Song, Bo, Johan Dalén, David Edler, et al.. (2007). Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk. Clinical Cancer Research. 13(12). 3748–3752. 24 indexed citations

20.

Bernander, Sverker, et al.. (1993). Absence ofHelicobacter pylori in dental plaques inHelicobacter pylori positive dyspeptic patients. European Journal of Clinical Microbiology & Infectious Diseases. 12(4). 282–285. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact